Sept 15 (Reuters) - Billionaire Ray Dalio, founder of one of the world's biggest hedge funds, has predicted a sharp plunge in stock markets as the U.S.
Keep Reading →
September 15 - Hedge Funds, Insider Trading - Comments
The selloff in crypto, as well as the broader market downturn, has left Anthony Scaramucci’s SkyBridge Capital’s flagship fund of funds down 25 percent for the year through...
Keep Reading →
August 22 - Hedge Funds, Insider Trading - Comments
Dalton Investments, a $3.4 billion U.S. investment firm, says it’s still on the fence over whether to support Shinsei Bank Ltd.’s management or SBI Holdings Inc.
Keep Reading →
November 18 - Hedge Funds, Insider Trading - Comments
In this article, we present to you the 12 best genomic stocks to buy now according to hedge funds.
Keep Reading →
December 23 - ETF Trading, Hedge Funds, News - Comments
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Keep Reading →
December 17 - ETF Trading, Hedge Funds, News, Tech - Comments
Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January 2016.
Keep Reading →
November 4 - Insider Trading, News - Comments
"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.
Keep Reading →
April 5 - Commodities, Gold, Market Movers, News, Tech - Comments
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to 'Buy' from 'Hold' and set a $45 target price.
Keep Reading →
April 5 - Market Movers, News - Comments
In a rather quiet market where the Dow is down but the S&P and NASDAQ are both up, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have rallied 3%, showing some solid relative...
Keep Reading →
March 22 - News - Comments
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the week’s biggest winners from the J.P.
Keep Reading →
January 11 - News, Stock Analysis - Comments
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know which stocks to choose...
Keep Reading →
December 1 - News, Stock Analysis - Comments
Jason Karp's Tourbillon Capital Partners has retaken a stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) after having sold off its previous position in the stock during the second...
Keep Reading →
October 28 - Hedge Funds, Market Movers, News - Comments
If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne muscular dystrophy.
Keep Reading →
October 19 - News - Comments
After yesterday's rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this article, we analyze some stocks...
Keep Reading →
October 12 - Market Movers, News - Comments
WTI crude futures have sank below the $50 per barrel mark around noon as traders brace for another potential rise in the rig count.
Keep Reading →
October 7 - News - Comments
In this article, we will analyze five stocks that are showing considerable more movement than the broader market and are attracting more interest, Bassett Furniture Industries...
Keep Reading →
September 29 - Market Movers, News - Comments
Broad markets are shaky today with NASDAQ trading in red territory.
Keep Reading →
September 28 - Market Movers, News - Comments
Wall Street is quiet today after the Federal Reserve's Wednesday decision of keeping interest rates the same.
Keep Reading →
September 22 - Earnings Report, Market Movers, News - Comments
There is little fear on the Street today, as all three major indexes are moderately higher.
Keep Reading →
September 20 - Market Movers, News - Comments
Among the stocks capturing attention from traders early this morning are SeaWorld Entertainment Inc (NYSE:SEAS), Ascena Retail Group Inc (NASDAQ:ASNA), Wal-Mart Stores, Inc.
Keep Reading →
September 20 - Market Movers, News - Comments
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the NASDAQ inching up 0.4%.
Keep Reading →
September 19 - Market Movers, News - Comments
Some stocks are nonetheless gaining ground this morning, including Sarepta Therapeutics Inc (NASDAQ:SRPT), At Home Group Inc.
Keep Reading →
September 14 - Market Movers, News - Comments
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now.
Keep Reading →
June 21 - News, Stock Analysis - Comments
The markets are in the green ahead of Tuesday's opening bell, with the S&P, Nasdaq, and Dow futures are all in positive territory, as are crude futures.
Keep Reading →
June 7 - Market Movers, News - Comments
The markets have been quiet so far today, amid news involving the ADP private payrolls rising by 173,000 for May and OPEC agreeing to maintain the status quo.
Keep Reading →
June 2 - Market Movers, News - Comments
Even though oil is down on Monday, U.S stocks are up, partly driven by strength in the financial and consumer discretionary sectors.
Keep Reading →
May 2 - Market Movers, News - Comments
Although the Dow Jones Index and the S&P 500 are each close to flat for the day, shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Textura Corp (NYSE:TXTR), Cliffs Natural...
Keep Reading →
April 28 - Market Movers, News - Comments
Markets opened higher on Tuesday as companies continue to announce quarterly financial results. A Federal Reserve policy meeting is also scheduled to start today.
Keep Reading →
April 26 - Market Movers, News - Comments
Although crude futures have rallied to almost break-even and most of the major earnings reports released so far aren't sharply negative in terms of those company's macro-economic...
Keep Reading →
April 21 - Market Movers, News - Comments
Piggybacking insider trading has been a profitable investment strategy over the past several decades or so based on research, though new regulations and an increased use of stock...
Keep Reading →
March 17 - Insider Trading, News - Comments
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Keep Reading →
February 27 - Hedge Funds, News - Comments
Market fear just isn't going away. With S&P futures down by 2% in the pre-market and crude prices breaking below $30 per barrel, Friday looks to be another volatile day.
Keep Reading →
January 15 - Market Movers, News - Comments
With markets slightly in the red on Wednesday, a number of stocks stood out as they are plunging in afternoon trading.
Keep Reading →
October 14 - Market Movers, News - Comments
Steve Cohen's Point72 Asset Management has upped its stake in two companies and added two new holdings to its equity portfolio, according to four separate Schedule 13G forms ...
Keep Reading →
May 5 - Hedge Funds, News - Comments
Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment vehicles of a forgotten age.
Keep Reading →
September 17 - News - Comments
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age.
Keep Reading →
September 11 - News - Comments
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
Keep Reading →
August 30 - News - Comments
If you were to ask many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News - Comments
In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it.
Keep Reading →
August 29 - News - Comments
Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene -- the largest gene on the X chromosome -- which affects one...
Keep Reading →
August 27 - News - Comments
While many investors worried about the Nasdaq's three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn't have come back up.
Keep Reading →
August 26 - News - Comments
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to track Mr. Market.
Keep Reading →
August 22 - News - Comments
At some point, a company reaches a level of maximum valuation. It doesn't mean the company becomes bad, but rather all upside is priced in and future gains are limited.
Keep Reading →
August 22 - News - Comments
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to lose more than half of its...
Keep Reading →
August 21 - News - Comments
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment, because these are exciting...
Keep Reading →
August 20 - News - Comments
On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)'s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc (NASDAQ:SRPT)'s competing Duchenne...
Keep Reading →
August 17 - News - Comments
Even with the broad-based S&P 500 retracing for three straight days amid worries that the Federal Reserve may begin paring back its monthly bond-buying program as early as next...
Keep Reading →
August 9 - News - Comments
It is not uncommon for a biotechnology company to be valued solely on the potential of one drug.
Keep Reading →
August 8 - News - Comments
